This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Glaucoma
and you are
over 18
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to evaluate differences between treatments in mean change from baseline in 24-hr intraocular pressure (IOP) at Week 4.

Provided treatments

  • Drug: Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspension
  • Drug: Vehicle
Tris trial is registered with FDA with number: NCT02770248. The sponsor of the trial is Alcon Research and it is looking for 162 volunteers for the current phase.
Official trial title:
24-hr Intraocular Pressure Control With Brinzolamide 1% / Brimonidine 0.2% Ophthalmic Suspension vs Vehicle